MIS 2014, Part 2: Opportunities And Challenges

The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.

As innovation continues to drive growth in the market for minimally invasive surgical products, manufacturers are faced with both opportunities and challenges. In terms of opportunities, a growing incidence of cancer, obesity, and other chronic diseases is fueling growth in the number of surgical procedures, and physicians are increasingly performing these procedures as MIS. Additionally, only one-third of all surgical procedures are currently performed as MIS, and manufacturers are targeting specific procedures, geographies, and physician specialties in an effort to increase MIS penetration and adoption. For example, although the vast majority of cholecystectomy procedures in the US are performed laparoscopically, there is an opportunity for greater MIS penetration in China and India, where physicians perform many of these procedures open. (See Exhibit 1.) (SeeAlso see "Covidien’s Project ADOPT: Moving The Needle On MIS" - Medtech Insight, 30 January, 2014..)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

South Korea Adds Digital Health Rules To Already Complicated Regulatory Landscape

 
• By 

A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

Q’Apel Medical Recalls, Discontinues Stroke Therapy System After FDA Warning Letter, Class I Designation

 

Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.

Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory Access

 
• By 

India’s medical technology industry is raising the alarm over steep new US tariffs on imported medical devices. It argues for structural change to address “unequal regulatory access” and non-tariff barriers.

More from Geography